Metformin and Sitagliptin
COMBINATION OF METFORMIN /SITAGLIPTIN ENHANCES CEREBRAL AUTOREGULATION IN PATIENTS WITH NEWLY DIAGNOSED TYPE2 DIABETES MELLITUS
6
DEVELOPMENT AND VALIDATION OF NEW ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN AND SITAGLIPTIN IN BULK AND DOSAGE FORM BY RP HPLC
10
ANTIPROLIFERATIVE AND APOPTOGENIC EFFICACY OF ANTIDIABETIC DRUGS METFORMIN AND SITAGLIPTIN AGAINST MCF7 AND HEPG2 CANCER CELLS: A COMPARATIVE MOLECULAR STUDY
11
Development of stability indicating RP-HPLC method for the determination of sitagliptin phosphate and metformin hydrochloride in tablet dosage form
8
HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN AND SITAGLIPTIN IN BULK AND PHARMACEUTICAL DOSAGE FORM
9
RP-HPLC method development and validation for simultaneous estimation of sitagliptin phosphate and metformin hydrochloride in tablet dosage form
7
A CROOS SECTIONAL STUDY IN NORTH EASTERN UTTAR PRADESH POPULATION FOR THE ESTIMATION OF HDL, TRIGLYCERIDES LEVELS IN RECENTLY DIAGNOSED PATIENTS WITH DIABETES MELLITUS TYPE 2 TAKING METFORMIN ALONE, METFORMIN WITH ADD ON SITAGLIPTIN AND SITAGLIPTIN ALONE
9
DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE IN TABLET DOSAGE FORM
8
STABILITY INDICATING RP HPLC METHOD AND ITS VALIDATION FOR ANALYSIS OF METFORMIN HYDROCHLORIDE & SITAGLIPTIN PHOSPHATE IN BULK AND PHARMACEUTICAL DOSAGE FORM
14
Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
8
“Effects of Metformin Alone and in Combination with Sitagliptin on Oxidative Stress and Proinflammatory Markers in Patients with Diabetes Mellitus Type-2” by Ali M. Al Hussona, Ahmed R. Abu-Raghif, Methaq A. Al Ghazi, Iraq.
6
Comparative study of efficacy and safety of sitagliptin versus glimepiride in patients of type-2 diabetes mellitus inadequately controlled with metformin alone
5
RP HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF METFORMIN HYDROCHLORIDE, ROSIGLITAZONE AND SITAGLIPTIN – APPLICATION TO COMMERCIALLY AVAILABLE DRUG PRODUCTS
10
ANALYTICAL AND BIOANALYTICAL UHPLC MS METHOD VALIDATION FOR DETERMINATION OF METFORMIN, A BIGUANIDE AND SITAGLIPTIN, A DPP 4 INHIBITOR
8
Development and Validation of a Method for Simultaneous Determination of Metformin Hydrochloride and Sitagliptin Phosphate in a Formulation by RP HPLC
6
Method development and validation for the simultaneous estimation of sitagliptin and metformin in tablet dosage form by RP-HPLC
7
Development and validation of analytical methods for simultaneous estimation of sitagliptin phosphate and metformin hydrochloride in bulk and tablets by using UV-spectroscopy
9
“Method Development and Validation of A Stability-Indicating Reversed-Phase Liquid Chromatographic Method for the Simultaneous Estimation of Metformin, Sitagliptin and Simvastatin in Presence of their Degradation Products” by N. C. Kotecha, J. K. Patel, India.
10
Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patients
7
“Simultaneous Determination of Metformin, Sitagliptin, Saxagliptin, Linagliptin and Vildagliptin in Multicomponent Pharmaceutical Preparations by RP-High Performance Liquid Chromatography” by Sanjay Pednekar, Rama Lokhande, Rajiv Sutar, Surekha Kolhal, Sandip Surve, Sanket Gudekar, India.
6